Adiponectin and TNF-alpha are present in damaged cardiomyocytes from patients with MI and DCM, suggesting a potential role in myocardial injury processes.
Answers are grounded in this paper and cite their sources.
May mark cardiomyocyte injury in MI/DCM; leaves open any causal or therapeutic role pending prospective studies.
This study determined the presence of adiponectin, T-cadherin (an adiponectin receptor) and tumour necrosis factor-alpha (TNF-alpha) in damaged myocytes from autopsied patients with acute or old myocardial infarction (MI) or dilated cardiomyopathy (DCM), using immunohistochemical staining. The enrolled patients included eight with acute MI, six with old MI and seven with DCM. Four autopsied individuals with no cardiac lesions were also enrolled as controls. Adiponectin and TNF-alpha were not observed in normal myocytes from control subjects, but T-cadherin was weakly detected. Immunoreactivity for adiponectin and T-cadherin was observed at the periphery of damaged myocytes from MI and DCM patients; intracellular reactivity for TNF-alpha was also seen. There were no statistically significant differences in the degree of reactivity for each molecule in the myocytes between the MI and DCM patients. These results suggest that the presence of adiponectin and TNF-alpha in damaged myocytes may contribute to the processes of myocardial injury occurring in MI and DCM.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: